BCL2L1 and cancer: Excepting the dominant-negative regulator of STAT3α, STAT3β can repress the expression of Bcl-xL, p21, cyclin D1, and cyclin C, inducing apoptosis and cell cycle arrest in cancer cells [21,26,55].